05:26 PM EST, 01/21/2025 (MT Newswires) -- RAMM Pharma (RAMM.CN) after trade Tuesday announced it is exploring strategic options for the potential sale of its Canapar subsidiary, and/or its industrial facility located in Ragusa, Italy.

This decision is part of RAMM's "ongoing efforts to streamline operations and focus on its operating businesses while seeking potential growth opportunities."

The potential sale is aimed at enhancing shareholder value and ensuring the long-term sustainability of the company.